Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Melanoma Res. 2011 Dec;21(6):547–554. doi: 10.1097/CMR.0b013e32834b58e4

Table 4.

Weighted Percent Distribution of Clinical Characteristics by Presence of an Approved Residency Training Program for Cases with Non-distant Melanoma

1995 1996 2001
Residency Training Approval No/Unk* Yes No/Unk* Yes No/Unk* Yes
Number of cases 102 161 361 391 365 355
Histology
 Malignant melanoma, NOS 33.2 27.6 37.7 32.3 43.3 35.4
 Superficial spreading 44.3 49.6 39.7 44.8 34.1 45.0
 Nodular 16.1 7.0 8.8 10.9 10.7 8.9
 Lentigo maligna melanoma 3.6 5.8 9.6 6.1 6.2 4.6
 Desmoplastic 0.5 2.9 0.1 0.9 1.2 1.4
 Other 2.3 7.0 4.1 5.1 4.5 4.6
Lymph Nodes Examined
 None 84.8 84.2 84.6 71.5 66.2 54.1
 1 node 3.0 5.2 2.3 8.4 9.8 11.8
 2-5 nodes 1.0 5.2 5.3 9.3 16.0 23.0
 6-10 nodes 2.6 1.0 2.1 3.1 3.2 3.0
 11+ nodes 5.6 4.0 3.9 5.8 2.4 6.3
 At least one, but number unknown 3.1 0.3 1.4 1.6 2.4 1.5
 Other 0.0 0.0 0.3 0.3 0 0.3
Technique of Lymph Node Dissection
 No LND 84.8 84.2 84.6 71.5 66.2 54.1
 Traditional 9.6 4 8.7 6.9 3.6 4.9
 Any Sentinel 1.7 10.3 6 20.1 28.6 38.7
 Technique Unknown 4 1.5 0.7 1.4 1.7 2.3
Margins
 < 1.0 cm 19.6 41.6 23.0 40.7 20.4 29.8
 >1.0 - 2.0 cm 14.1 17.0 13.3 25.2 13.8 24.5
 >2.0 cm 11.8 4.6 18.0 10.2 5.4 7.5
 Margins clear, NOS 0 0 4.6 1.9 39.8 25.4
 Tumor at margin 2.6 3.3 1.5 2.7 2.6 2.9
 Not stated/Unknown 51.9 33.5 39.6 19.3 18.1 9.9
Treatment
 No treatment reported 0.0 0.0 0.0 0.0 0.0 0.0
 Surgery Only 91.1 91.9 87.5 86.2 95.2 91.3
 Chemo/Immunotherapy Only 0.1 0 0 0 0 0.4
 Surgery and Chemo/Immunotherapy 8.0 2.7 5.6 8.9 3.2 7.4
 Surgery and XRT 0 1.8 0.9 0.3 0.5 0.3
 Surgery, XRT, and Chemotherapy 0 0 0.7 0.8 0 0.2
 Unknown 0.8 3.7 5.3 3.8 1.0 0.4
*

Unknown